Key result
HCV seropositivity is not linked to increased insulin resistance or arterial stiffness in hemodialysis patients.
Why the study?
Hepatitis C virus seropositivity is correlated with carotid artery plaque formation and type 2 diabetes mellitus in the general population, and insulin resistance is a risk factor for atherosclerosis. Determining the impact of HCV on insulin resistance and arterial stiffness in hemodialysis patients would help prevent related cardiovascular complications.
Observational (n=67)
Answers are grounded in this paper and cite their sources.
HCV may worsen insulin resistance and stiffness in HD patients; leaves open whether antiviral therapy alters CV outcomes in this group.
AIM: It has been shown that Hepatitis C virus (HCV) seropositivity and carotis artery plaque formation are independently correlated in the general population. Insulin resistance is also a risk factor for atherosclerosis. The association between HCV and type 2 diabetes mellitus is known. Determination of the impact of HCV on insulin resistance and arterial stiffness in hemodialysis patients would help to prevent related cardiovascular complications. METHODS: Thirty-seven HCV(+) and 30 HCV(-) HD patients were enrolled in this study. All patients were non-diabetic. Insulin resistance was assessed by "HOMA-IR." Arterial stiffness was measured by "stiffness index b" and "elastic modulus." RESULTS: In the HCV(+) group, there were 20 males and 17 females, while the HCV(-) group had 19 males and 11 females. The mean age was 43.4 +/- 16.7 years and 44.5 +/- 16.8 years, respectively. The HOMA-IR was 1.50 in HCV(+) group and 1.31 in HCV(-) group (p > 0.05). Stiffness index b and elastic modulus measurements revealed no difference between groups. In the HCV(+) group, arterial stiffness parameters were correlated with age, white blood cell, thrombocyte, total and LDL cholesterol, uric acid, mean arterial pressure, diastolic blood pressure, and HOMA-IR. There was no association between arterial stiffness and the above-mentioned parameters in the HCV(-) group. CONCLUSION: We found that there was no association of arterial stiffness in HCV(+) patients with insulin resistance. Further studies with larger patient groups and more sensitive methods of detecting HCV are needed. This study is the first in literature on this issue.
No takes yet. Share an insight, caveat, or question.
Adam et al. (2008) conducted an observational in Hemodialysis patients (with and without Hepatitis C virus seropositivity) (n=67). Hepatitis C virus seropositivity (HCV+) vs. Hepatitis C virus seronegativity (HCV-) was evaluated on Insulin resistance (HOMA-IR) and arterial stiffness (stiffness index b and elastic modulus) (p=>0.05). HCV seropositivity in non-diabetic hemodialysis patients did not increase insulin resistance or arterial stiffness compared to HCV-negative controls.
Synapse has enriched 10 related papers. Consider them for comparative context: